The overall goal of the Moffitt Cancer Center (MCC) Health Outcomes and Behavior (HOB) Program is to contribute to the prevention, detection, and control of cancer through the study of health-related behaviors, health care practices, and health-related quality of life. Work toward this goal involves research across the disease spectrum ? from prevention and detection through to survivorship or advanced disease. To accomplish its goal, the Program's Specific Aims are: (1) Understand the determinants of behaviors that can lead to prevention and early detection of cancer and develop effective methods of promoting those behaviors; (2) Understand and improve the quality of life of patients and family members throughout the disease course; (3) Contribute to the evidence base, and synthesis of evidence, regarding delivery of cancer care and clinical outcomes; and (4) Understand and intervene upon the social, cultural, and behavioral determinants of cancer- related health disparities. The program comprises 27 members [20 MCC faculty; seven University of South Florida (USF) faculty] from 12 different academic departments (six MCC and six USF). During the reporting period, 547 cancer-related articles have been published, with 218 (40%) representing intra-programmatic collaborations and 135 (25%) representing inter-programmatic collaborations. Inter-institutional collaborations with other NCI-designated Cancer Centers represent 164 (30%) of the publications. Total grant funding for the program currently is $9.1 million in annual total costs, of which $7.5 million is peer-reviewed, including $3.0 million from NCI. Program members conduct hypothesis-driven observational and intervention research on the major cancers affecting the catchment area?lung, prostate, breast, colorectal, cervical?with respect to prevention, screening, quality of life, cancer care delivery, and outcomes. Additionally, toward the goal of reducing cancer- related health disparities, program members conduct community-based participatory research in concert with organizations embedded in the catchment area. In collaboration with colleagues from other programs and institutions, translational research by HOB members is driving public health policy and clinical practice.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA076292-19
Application #
9209829
Study Section
Subcommittee A - Cancer Centers (NCI-A)
Project Start
Project End
Budget Start
2017-02-01
Budget End
2018-01-31
Support Year
19
Fiscal Year
2017
Total Cost
$31,374
Indirect Cost
$13,133
Name
H. Lee Moffitt Cancer Center & Research Institute
Department
Type
Research Institutes
DUNS #
139301956
City
Tampa
State
FL
Country
United States
Zip Code
33612
Ctortecka, Claudia; Palve, Vinayak; Kuenzi, Brent M et al. (2018) Functional Proteomics and Deep Network Interrogation Reveal a Complex Mechanism of Action of Midostaurin in Lung Cancer Cells. Mol Cell Proteomics 17:2434-2447
Ferreiro-Iglesias, Aida; Lesseur, Corina; McKay, James et al. (2018) Fine mapping of MHC region in lung cancer highlights independent susceptibility loci by ethnicity. Nat Commun 9:3927
Schmit, Stephanie L; Edlund, Christopher K; Schumacher, Fredrick R et al. (2018) Novel Common Genetic Susceptibility Loci for Colorectal Cancer. J Natl Cancer Inst :
Kang, Sokbom; Thompson, Zachary; McClung, E Claire et al. (2018) Gene Expression Signature-Based Prediction of Lymph Node Metastasis in Patients With Endometrioid Endometrial Cancer. Int J Gynecol Cancer 28:260-266
Kowalski, Allison; Striley, Catherine Woodstock; Varma, Deepthi Satheesa et al. (2018) Interactions between Alcohol Consumption and Adjuvant Hormone Therapy in Relation to Breast Cancer-Free Survival. J Breast Cancer 21:158-164
Konno, Hiroyasu; Yamauchi, Shota; Berglund, Anders et al. (2018) Suppression of STING signaling through epigenetic silencing and missense mutation impedes DNA damage mediated cytokine production. Oncogene 37:2037-2051
Gonzalez, Brian D; Hoogland, Aasha I; Kasting, Monica L et al. (2018) Psychosocial impact of BRCA testing in young Black breast cancer survivors. Psychooncology 27:2778-2785
Akuffo, Afua A; Alontaga, Aileen Y; Metcalf, Rainer et al. (2018) Ligand-mediated protein degradation reveals functional conservation among sequence variants of the CUL4-type E3 ligase substrate receptor cereblon. J Biol Chem 293:6187-6200
Mahajan, Nupam P; Coppola, Domenico; Kim, Jongphil et al. (2018) Blockade of ACK1/TNK2 To Squelch the Survival of Prostate Cancer Stem-like Cells. Sci Rep 8:1954
Rounbehler, Robert J; Berglund, Anders E; Gerke, Travis et al. (2018) Tristetraprolin Is a Prognostic Biomarker for Poor Outcomes among Patients with Low-Grade Prostate Cancer. Cancer Epidemiol Biomarkers Prev 27:1376-1383

Showing the most recent 10 out of 1254 publications